Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2022 R21 RFA-CA-21-003 GIBBS, SUMMER LYNNE OREGON HEALTH & SCIENCE UNIVERSITY A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors Active
1999 R21 PAR-98-067 STRAUSS, WILLIAM M BETH ISRAEL DEACONESS MEDICAL CENTER EVALUATION OF SEQUENCE SPECIFIC CHANGES IN GENOMIC DNA Complete
2007 R21 RFA-CA-07-002 GARRAWAY, LEVI ALEXANDER DANA-FARBER CANCER INST HIGH-THROUGHPUT ONCOGENE MUTATION DETECTION IN HUMAN CANCER Complete
2017 R21 RFA-CA-16-001 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA A Target-Directed Reagent Pipeline via Microfluidic mRNA Display Complete
2020 R21 RFA-CA-19-019 SHVETS, GENNADY CORNELL UNIVERSITY Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces Active
2006 R21 RFA-CA-06-004 HSI, ERIC CLEVELAND CLINIC LERNER COL/MED-CWRU CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 MC GOWN, LINDA B. RENSSELAER POLYTECHNIC INSTITUTE HYBRIDIZATION OF PROMOTER DNA TARGETS IN CHROMATIN TO DISCOVER REGULATORY PROTEIN Complete
2013 R21 RFA-CA-12-002 CASTRO, CARLOS E. OHIO STATE UNIVERSITY NANOSCALE TOOLS FOR FUNCTIONAL STUDIES OF CANCER-RELEVANT CHROMATIN MODIFICATIONS Complete
2016 R21 RFA-CA-15-002 SADEGHI , SAMAN UNIVERSITY OF CALIFORNIA LOS ANGELES ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS Complete
2000 R21 PAR-99-100 CHEE, MARK S. ILLUMINA, INC. PROTEIN PROFILING ARRAYS Complete
2008 R21 RFA-CA-07-037 KNUDSEN, BEATRICE S FRED HUTCHINSON CANCER RESEARCH CENTER TISSUE LYSATES FOR STUDIES OF PROTEIN PHOSPHORYLATION Complete
2011 R21 RFA-CA-10-005 SHENDURE, JAY ASHOK UNIVERSITY OF WASHINGTON ULTRASENSITIVE IDENTIFICATION AND PRECISE QUANTITATION OF LOW FREQUENCY SOMATIC M Complete
2005 R21 RFA-CA-05-002 WYMAN, ROBERT J YALE UNIVERSITY GENETIC METHODS FOR DETECTING GAP JUNCTION COMMUNICATION Complete
2021 R21 CA20-017 FARIS, GREGORY W NUMENTUS TECHNOLOGIES INC. Decoding Individual Exosomes in Cancer NCE
1999 R21 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2007 R21 RFA-CA-07-002 SEGALL, JEFFREY E ALBERT EINSTEIN COLLEGE OF MEDICINE DEVELOPMENT OF AN IN VIVO METASTASIS SCREEN Complete
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing Complete
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2006 R21 RFA-CA-06-004 COTE, RICHARD JAMES UNIVERSITY OF SOUTHERN CALIFORNIA INTEGRATED MICRODEVICE TO CAPTURE AND DETECT CIRCULATING TUMOR CELLS Complete
2009 R21 RFA-CA-08-006 CHAREST, JOSEPH LEO CHARLES STARK DRAPER LABORATORY MICROFLUIDIC 3D SCAFFOLD ASSAY FOR CANCER CELL MIGRATION AND INTRAVASATION Complete
2013 R21 RFA-CA-12-002 BAI, MINGFENG UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND TREATMENT MONITORING Complete
2016 R21 RFA-CA-15-002 SEGAL, DAVID J UNIVERSITY OF CALIFORNIA AT DAVIS CRISPR-BASED EPIGENETIC MODIFIERS Complete
2000 R21 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2011 R21 RFA-CA-10-005 HUANG, SONGPING D KENT STATE UNIVERSITY AT KENT PRUSSIAN BLUE NANOPARTICLES AS CELLULAR T1 MRI CONTRAST AGENTS Complete
2005 R21 RFA-CA-05-002 MURPHY, JOHN R. BOSTON MEDICAL CENTER NOVEL TARGETED REAGENTS THAT MODIFY ONCOGENE EXPRESSION Complete
2015 R21 RFA-CA-14-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN DROPLET MICROFLUIDIC PLATFORM FOR ULTRALOW INPUT EPIGENETICS Complete
2021 R21 CA20-017 DIDENKO, VLADIMIR V BAYLOR COLLEGE OF MEDICINE In situ assay imaging nuclear RNA exosome activity for cancer studies Active
1999 R21 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete
2007 R21 RFA-CA-07-002 SHEA, LONNIE D NORTHWESTERN UNIVERSITY TRANSFECTED CELL ARRAYS FOR CANCER RESEARCH Complete
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications Complete
2009 R21 RFA-CA-08-006 LARSON, DALE N CHARLES STARK DRAPER LABORATORY THE DEVELOPMENT OF A CHIP-SCALE NANO-CALORIMETER Complete
2013 R21 RFA-CA-12-002 WILLIAMS, JOHN CHARLES BECKMAN RESEARCH INSTITUTE/CITY OF HOPE OPTIMIZATION OF MULTIVALENT LIGANDS BY SUPER-RESOLUTION MICROSCOPY TO TREAT CANCE Complete
2000 R21 PAR-99-100 STANTON, MARTIN J BRANDEIS UNIVERSITY APTAMER BASED DETECTOR TO QUANTIFY MACROMOLECULES Complete
2002 R21 PAR-01-104 YEUNG, EDWARD S. IOWA STATE UNIVERSITY SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING Complete
2005 R21 RFA-CA-05-002 WANG, BINGHE GEORGIA STATE UNIVERSITY FLUORESCENT APTAMERS FOR GLYCOPROTEIN DETECTION Complete
2008 R21 RFA-CA-07-022 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY SURROGATE AND SENTINAL TECHNOLOGIES TO MONITOR STABILITY OF CANCER PHOSPHOPROTEIN Complete
2015 R21 RFA-CA-14-003 ELLINGTON, ANDREW D UNIVERSITY OF TEXAS, AUSTIN HIGH THROUGHPUT SINGLE CELL TRANSCRIPTOME ANALYSIS Complete
2021 R21 CA20-017 HAINER, SARAH JANE UNIVERSITY OF PITTSBURGH AT PITTSBURGH Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN Active
1999 R21 PAR-98-067 VIDAL, MARC MASSACHUSETTS GENERAL HOSPITAL NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING Complete
2007 R21 RFA-CA-07-002 YEE, CASSIAN FRED HUTCHINSON CAN RES CTR IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CANCER Complete
2010 R21 RFA-CA-09-004 WILLEY, JAMES C. UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS IMPLEMENTATION OF INNOVATIVE RNA SAMPLE QUALITY CONTROL METHODS Complete
2017 R21 RFA-CA-16-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer Complete
2009 R21 RFA-CA-08-006 SHAPIRO, BENJAMIN UNIV OF MARYLAND, COLLEGE PARK SPATIAL, HIGH-ACCURACY, MULTIPLEXED MAPPING OF GENES IN HUMAN TISSUE SECTIONS Complete
2013 R21 RFA-CA-12-002 SOPER, STEVEN ALLAN UNIV OF NORTH CAROLINA CHAPEL HILL ACUTE MYELOID LEUKEMIA: MRD ANALYSIS USING MODULAR UFLUIDICS AND UFLOW CYTOMETRY Complete
2019 R21 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Complete
2000 R21 PAR-99-102 GRIFFITH, JEFFREY K UNIVERSITY OF NEW MEXICO PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete

Pages